Your browser doesn't support javascript.
loading
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients.
Carbone, Maria Luigia; Madonna, Gabriele; Capone, Alessia; Bove, Marianna; Mastroeni, Simona; Levati, Lauretta; Capone, Mariaelena; Ascierto, Paolo Antonio; De Galitiis, Federica; D'Atri, Stefania; Fortes, Cristina; Volpe, Elisabetta; Failla, Cristina Maria.
Afiliación
  • Carbone ML; Experimental Immunology Laboratory, IDI-IRCCS, Via Monti di Creta 104, 00167, Rome, Italy. marialuigia.carbone@idi.it.
  • Madonna G; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola 53, 80131, Naples, Italy.
  • Capone A; Molecular Neuroimmunology Unit, IRCCS Fondazione Santa Lucia, 00143, Rome, Italy.
  • Bove M; Experimental Immunology Laboratory, IDI-IRCCS, Via Monti di Creta 104, 00167, Rome, Italy.
  • Mastroeni S; Epidemiology Unit, IDI-IRCCS, Via Monti di Creta 104, 00167, Rome, Italy.
  • Levati L; Molecular Oncology Laboratory, IDI-IRCCS, Via Monti di Creta 104, 00167, Rome, Italy.
  • Capone M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola 53, 80131, Naples, Italy.
  • Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola 53, 80131, Naples, Italy.
  • De Galitiis F; Oncology Department, IDI-IRCCS, Via Monti di Creta 104, 00167, Rome, Italy.
  • D'Atri S; Molecular Oncology Laboratory, IDI-IRCCS, Via Monti di Creta 104, 00167, Rome, Italy.
  • Fortes C; Epidemiology Unit, IDI-IRCCS, Via Monti di Creta 104, 00167, Rome, Italy.
  • Volpe E; Molecular Neuroimmunology Unit, IRCCS Fondazione Santa Lucia, 00143, Rome, Italy.
  • Failla CM; Experimental Immunology Laboratory, IDI-IRCCS, Via Monti di Creta 104, 00167, Rome, Italy.
Sci Rep ; 12(1): 5448, 2022 03 31.
Article en En | MEDLINE | ID: mdl-35361879

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vitíligo / Hipopigmentación / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vitíligo / Hipopigmentación / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido